Fest trumpets HIV awareness
Hot dogs, games and face painting were part of the free National HIV Testing Day Tuesday at Mansion Square Park in Poughkeepsie.

AIDS Healthcare Foundation slams pricing of Prezista
The Los Angeles–based AIDS Healthcare Foundation is blasting drugmaker Tibotec, a subsidiary of Johnson & Johnson, for what it says is an expected high price tag for the newly approved protease inhibitor Prezista, which is designed to treat drug-resistant HIV infections.

CHAVI Announces International Search for Genes Affecting HIV Response
DURHAM, N.C. -- A pioneering collaboration among U.S., European and Australian researchers announced June 20, 2006, will seek to identify genetic differences in the way people respond to HIV.

Save children before they are born
Prospective couples’ medical examinations — costing a few thousand rupees — before they get married can save innocent children from leading a crippled life because of diseases like thallesaemia, HIV/ADIS and hepatitis.

Ore. researchers discover new hope for HIV patients
Oregon Health & Science University researchers have discovered a possible HIV therapy that replaces cells damaged by AIDS.

New drugs inspire caution
A meeting of doctors, scientists and community advocates in Washington, DC has recommended that the development of a new class of anti-HIV drugs, the CCR5 inhibitors, should continue ‘with caution’.